arrow
U

Ursula Wiedermann

Medical University of Vienna
H指数:45
被引数:6,575

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vaccination policies for healthcare personnel in Europe, 2026

欧洲医疗保健人员疫苗接种政策,2026

Vaccine
IF3.5
2026-07-010
PRE
Obituary: Professor Dietrich Kraft (1937–2026)

讣告:迪特里希·克拉夫特教授(1937—2026)

2026-04-160
PRE
Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells
2024-10-210
OA
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines

基于PreS的重组疫苗VVX001在对基于HBsAg的HBV疫苗的低应答者中诱导乙型肝炎病毒中和抗体

2024-09-300
OAAI
Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON)

HER-Vaxx II期临床试验的最终结果,该试验采用基于B细胞肽的疫苗联合化疗标准治疗方案,用于HER2过表达的晚期胃癌患者 - (HERIZON)

2024-09-010
PRE
Streamlining malaria prevention recommendations for travellers: current and future approaches
2024-08-212
PRE
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy

新型冠状病毒肺炎加强疫苗接种的免疫原性和安全性: 一项基于人群的临床试验,以确定最佳的疫苗接种策略

2024-08-012
PRE
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants

SARS-CoV-2-Vaccinated多发性骨髓瘤患者的突破性感染改善了针对Omicron变体的交叉保护

2024-05-093
OAAI
Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+metastatic or advanced gastric/GEJ adenocarcinoma - Final results from Phase II/HERIZON study
2024-04-050
PRE
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains

基于流式细胞术的细胞表面表达的折叠SARS-CoV-2受体结合域特异性抗体的测量

2024-04-010
OAAI
Extracellular vesicles of the probiotic bacteria E. coli O83 activate innate immunity and prevent allergy in mice (vol 21, 297, 2023)
2023-12-060
OAAI
Extracellular vesicles of the probiotic bacteria E. coli O83 activate innate immunity and prevent allergy in mice
2023-10-2010
OAAI
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-a-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation

在抗tnf-a治疗的IBD患者中,对SARS-CoV-2疫苗的抗体反应幅度较低和减弱更快,与cTfh1细胞缺乏活化和扩增以及B记忆细胞形成受损有关

2023-10-0110
OAAI